Article: Kytril(R) Now Available In Oral Solution - New Option for Patients -.

NUTLEY, N.J. -- NUTLEY, N.J., Dec. 17 /PRNewswire/ -- Roche announced today its antiemetic Kytril(R) (granisetron hydrochloride) is now available in an oral solution for chemotherapy (CINV) and radiation (RINV) induced nausea and vomiting.

"We are very excited about this convenient new formulation which will offer healthcare providers another alternative for administering Kytril," said Dr. Andrew Coop, Medical Director, Roche. "Specifically, Kytril Oral Solution will give patients who have difficulty swallowing as a result of chemotherapy or radiation therapy a new treatment option."

In clinical trials, a 2-mg dose of Kytril Oral Solution proved to be ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!